Egyptian International Pharmaceutical Industries Company (EGX: PHAR)

Market Cap	7.33B
Revenue (ttm)	6.34B
Net Income (ttm)	1.09B
Shares Out	148.76M
EPS (ttm)	7.34
PE Ratio	6.71
Forward PE	n/a
Dividend	1.00 (2.03%)
Ex-Dividend Date	Apr 28, 2024

Volume	533,944
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	32.23 - 53.49
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 10, 2024

About PHAR

Egyptian International Pharmaceutical Industries Company manufactures and distributes medicines, and medical and veterinary preparations in Egypt and internationally. It produces various dosage forms, such as spansule capsules, soft gelatin capsules, lyophilized products, gels, sprayers, and effervescent tablets, as well as antibiotics. The company also provides Covid-19 related protocol medicine, including epicehin, epizithro, cetal, dexamethasone, and cevitil. gyptian International Pharmaceutical Industries Company was incorporated in 1980 an...

• Industry: Pharmaceutical Preparations
• Founded: 1980
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: PHAR

Financial Performance

In 2023, PHAR's revenue was 5.23 billion, an increase of 32.27% compared to the previous year's 3.96 billion. Earnings were 822.32 million, an increase of 27.89%.